1Ruzicka T, Assmann T, Homey B. Tacrolimus: The drug for the turn of the millennium[J]. Arch Dermatol,1999, 135 (5): 574. 被引量：1
2Schreiber SL, Crabtree GR. The mechanism of action of cyclosporing A and FK-506 [J]. Immunol Today,1992, 13:136. 被引量：1
3Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506) [J]. J Allergy Clin Immunol, 2001, 107: 345. 被引量：1
4Stuetz A, Grassberger M, Meingassner JG. Pimecrolimus ( Elidel, SDZ ASM981 ) -preclinical pharmacologic profile and skin selectivity[J]. Semin Cutan Med Surg, 2001, 20 (4): 233. 被引量：1
5Boguniewicz M, Leung DY. Pathophysiologic mechanisms in atopic dermatitis[J]. Semin Cutan Med Surg,2001, 20 (4): 217. 被引量：1
6Hanifin J M, Ling M R, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part Ⅰ, efficacy [J]. J Am Acad Dermatol,2001, 44(1): S28. 被引量：1
7Soter N A, Fleischer A B, Webster G F, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part Ⅱ, safety[J], J Am Acad Dermatol,2001, 44(1): S39. 被引量：1
8Paller A, Eichenfield L F, Leung D Y M, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patiems[J]. J Am Acad Dermatol, 2001, 44(1): S47. 被引量：1
9Reitamo S, Wollenberg A, Schopf E, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis[J]. Arch Dermatol,2000, 136(8): 999. 被引量：1
10Kang S, Lucky A W, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children[J]. J Am Acad Dermatol, 2001, 44(1): S58. 被引量：1
